Gentian Diagnostics ASA — Director's Dealing 2019

Feb 28, 2019

Primary insider notification

Primary insider notification

Moss, 28 February 2019

Njaal Kind, Chief Financial Officer of Gentian Diagnostics AS, has today acquired 10,000 shares in Gentian Diagnostics AS at an average price of NOK 56.00 per share.

Following this share purchase Mr. Kind owns 10,000 shares and 34,991 options in Gentian Diagnostics AS.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.